According to WHO's latest report, Belarus is listed as a multidrug-resistant TB high burden country. We are supporting the Ministry of Health in four TB facilities across Minsk city and region. Minsk is also a site for two clinical studies into shorter, innovative TB regimens which use newer TB drugs, TB PRACTECAL and endTB.
In Orsha, teams also treat inmates of a prison with DR-TB and co-infections such as hepatitis C, for which they receive direct-acting antiviral drugs.
Our activities in 2023 in Belarus
Data and information from the International Activity Report 2023.
37
37
1.7 M€
1.7M
2015
2015
![Belarus IAR map 2023 Belarus IAR map 2023](https://img.msf.org/AssetLink/j653a5ybbe3mkox6y4m04387cy66sf07.jpg)
![](/themes/custom/msf_theme/src/kss/components/image/assets/bg-transparent.png)
220
22
![Andrey and Polina TB Patients Andrey and Polina TB Patients](https://img.msf.org/AssetLink/xx812c824v5g6564g1lx8w5ihyw16m6o.jpg)
Voices from the field
This experience has changed our outlook on life.Polina, a patient taking part in MSF's TB trial